Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions

Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions

Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among  the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus  formation, systemic inflammatory reaction, the consequence...

Full description

Bibliographic Details
Main Authors: V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-04-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
covid-19
cognitive impairment
treatment
vinpocetine
Online Access:https://nnp.ima-press.net/nnp/article/view/1551
Description
Summary:Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among  the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus  formation, systemic inflammatory reaction, the consequences of mechanical ventilation and drug sedation are considered. Treatment strategies  for COVID-19 patients with CI have not yet been developed. The following tactics of patient management is advisable: prevention of  re-infection, assessment and correction of the emotional state,  treatment of cardiovascular diseases. The possibilities of  vinpocetine in the treatment of CI after COVID-19 are discussed.
ISSN:2074-2711
2310-1342

Similar Items